Marker Therapeutics is trading at $1.14 (-6.96%) in after-hours action following a regular-session gain to $1.22, a move likely driven by profit-taking and thin liquidity.
- The decline follows a strong performance during the regular session amid a broader biotech rebound, with no company-specific news, earnings, or fundamental catalysts reported.
- The move appears to be stock-specific rather than market-driven, as broader U.S. equities remained firm throughout the day.
- The price action is consistent with typical after-hours volatility in the absence of new fundamental updates.